ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

46.56
3.57
( 8.30% )
Updated: 13:57:19

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
46.56
Bid
46.36
Ask
46.56
Volume
142,960
43.19 Day's Range 46.97
27.02 52 Week Range 73.00
Market Cap
Previous Close
42.99
Open
44.33
Last Trade
13
@
46.46
Last Trade Time
13:57:46
Financial Volume
$ 6,590,696
VWAP
46.1017
Average Volume (3m)
334,801
Shares Outstanding
36,083,886
Dividend Yield
-
PE Ratio
-10.95
Earnings Per Share (EPS)
-4.24
Revenue
151k
Net Profit
-152.99M

About Keros Therapeutics Inc

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Dover, Delaware, USA
Founded
1970
Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KROS. The last closing price for Keros Therapeutics was $42.99. Over the last year, Keros Therapeutics shares have traded in a share price range of $ 27.02 to $ 73.00.

Keros Therapeutics currently has 36,083,886 shares outstanding. The market capitalization of Keros Therapeutics is $1.55 billion. Keros Therapeutics has a price to earnings ratio (PE ratio) of -10.95.

KROS Latest News

Keros Therapeutics Announces Leadership Updates

LEXINGTON, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery...

Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association

Elritercept continued to demonstrate a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion burden Durable clinical responses were...

Keros Therapeutics to Host a Corporate Update Conference Call and Webcast

LEXINGTON, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.6311.042213212541.9346.9740.9331735342.41087088CS
4-2.24-4.5901639344348.850.2140.9343519845.09730203CS
12-12.74-21.483979763959.362.1940.9333480149.95530058CS
26-2.8-5.6726094003249.367340.9335875956.23081833CS
527.0717.903266649839.497327.0231913047.15949557CS
1564.9111.788715486241.657324.3823425345.45251778CS
26026.46131.64179104520.188.820.120458447.24660127CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LCFYLocafy Ltd
$ 8.20
(253.43%)
39.09M
NEXINexImmune Inc
$ 5.681
(145.93%)
25.47M
BDRXBiodexa Pharmaceuticals PLC
$ 1.05
(47.66%)
59.75M
KZIAKazia Therapeutics Ltd
$ 0.98
(46.66%)
196.61M
CYNCYNGN Inc
$ 5.7402
(44.95%)
14.4M
IVPInspire Veterinary Partners Inc
$ 5.15
(-30.41%)
2.32M
CETUUCetus Capital Acquisition Corporation
$ 7.00
(-29.72%)
1.42k
SLRXSalarius Pharmaceuticals Inc
$ 2.06
(-24.89%)
1.89M
CINGCingulate Inc
$ 0.4887
(-24.58%)
1.25M
SAISAI TECH Global Corporation
$ 0.9112
(-20.77%)
333.21k
NVDANVIDIA Corporation
$ 127.92
(-5.18%)
246.83M
MAXNMaxeon Solar Technologies Ltd
$ 0.2162
(2.56%)
200.74M
KZIAKazia Therapeutics Ltd
$ 0.98
(46.66%)
184.92M
TSLATesla Inc
$ 244.0301
(-7.30%)
158.28M
SQQQProShares UltraPro Short QQQ
$ 7.665
(6.90%)
137.38M